Quick Takeaways
- Pablo J. Cagnoni has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $25,349,778.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Pablo J. Cagnoni
- Location
- South San Francisco, CA
- Summary
- The estimated net worth of Pablo J. Cagnoni is at least $25,349,778 dollars as of 21 Apr 2026. Pablo J. Cagnoni is the President, Global Head of R&D of INCYTE CORP and owns shares of INCYTE CORP (INCY) stock worth about $25.35M.
- Signature
- /s/ Elizabeth Feeney, Attorney-In-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Pablo J. Cagnoni and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: INCYTE CORP ($25,349,778).
- Past-year value change for that position: -$5,444,331.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Pablo J. Cagnoni
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| INCY | INCYTE CORP | President, Global Head of R&D | $25,349,778 | -$5,444,331 | -18% | 17 Apr 2026 |
| FUSN | Fusion Pharmaceuticals Inc. | Director | 04 Jun 2024 | |||
| RUBY | Rubius Therapeutics, Inc. | Director | 01 Feb 2023 |
Insider Transactions Reported by Pablo J. Cagnoni:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.